Europee, Renzi all'attacco: "Meloni, Tajani, Calenda e Schlein? Truffatori". Ecco perché
- 29
Il Fatto Quotidiano
Lastest news
- Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
- SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of N-able, Inc. (NYSE: NABL) and Encourages Shareholders to Contact the Firm for Additional Information
- Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
- Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
- Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response